Related Experiment Video
Updated: Sep 20, 2026
Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Can serum lipid and CRP levels predict the "severity" of aortic valve stenosis?
Huseyin Gunduz1, Ramazan Akdemir, Emrah Binak
1Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Department of Cardiology. drhuseyingunduz@yahoo.com
Insights
Serum cholesterol and CRP levels do not significantly correlate with aortic valve stenosis (AVS) severity. However, elevated lipid levels in AVS patients may indicate coronary artery disease (CAD), suggesting targeted screening for cardiovascular risk.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Hypercholesterolemia and inflammation are implicated in aortic valve stenosis (AVS) etiology.
- Predictive value of these factors for AVS progression and severity remains unclear.
- Understanding degenerative factors can lead to preventive strategies and clinical benefits.
Purpose of the Study:
- To investigate the correlation between serum cholesterol, triglyceride, and C-reactive protein (CRP) levels.
- To assess the relationship with echocardiographically determined aortic stenosis severity in AVS patients.
Main Methods:
- Doppler echocardiography used to calculate aortic valvular areas in 60 AVS patients.
- Patients categorized into mild, moderate, and advanced AVS groups (20 each).
- Subclassification based on the presence or absence of coronary artery disease (CAD).
Main Results:
- No statistically significant difference in total cholesterol and CRP levels among mild, moderate, and advanced AVS groups (p>0.05).
- Serum lipid levels were notably higher in AVS patients with co-existing coronary artery disease (CAD).
- Severity of AVS did not show a significant correlation with hypercholesterolemia and CRP levels.
Conclusions:
- AVS severity is not significantly associated with hypercholesterolemia and CRP levels.
- Elevated lipid levels in AVS patients are more indicative of concurrent CAD than AVS severity.
- Investigating CRP and lipid levels may benefit patients with higher cardiovascular risks, potentially aiding preventive treatment and cholesterol-lowering drug efficacy.
Background:
Results of the studies performed have suggested that hypercholesterolaemia and inflammation are important aetiologic factors in aortic valve stenosis (AVS). However up to now no such data has been obtained to evaluate whether these predictors may still serve as valuable tools to estimate the progression and severity of AVS. If factors contributing to the "progression" of degenerative process can be understood and preventive measures can be taken, both clinical and economical beneficial effects can be achieved. The objective of this study is to investigate the correlation of serum cholesterol, triglyceride and CRP levels with the severity of aortic stenosis echocardiographically evaluated in patients with aortic valve stenosis.
Material And Methods:
Aortic valvular areas of 60 patients (pts) hospitalized in our clinic with suspected AVS were calculated with Doppler echocardiography. Patients were grouped into mild, moderate and advanced AVS, each category containing 20 pts, and then were subclassified regarding those with and without coronary artery disease (CAD).
Results:
Total cholesterol and CRP levels were found to be 215+/-42 mg/dl and 2.0+/-1.4 mg/dl; 224+/-43 mg/dl and 2.4+/-2.1 mg/dl; 225+/-55 mg/dl and 2.7+/-2.1 mg/dl in pts with mild, moderate and advanced AVS, respectively. A statistically significant difference was not detected among the three groups (p>0.05). When subclasses were classified the levels were found to be much more increased in those patients having additional CAD.
Conclusion:
We have demonstrated that severity of AVS does not correlate significantly with hypercholesterolaemia and CRP and their levels do not rise in accordance with increasing severity of AVS. Elevations of lipid levels in AVS were found to correlate with the presence of CAD rather than the severity of AVS. So, not in patients with simply AVS but in patients under higher cardiovascular risks, investigation of CRP plus lipid levels might provide benefit with respect to preventive treatment and benefit from cholesterol-lowering drugs can be expected in such kind of patients.
More Related Videos
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies